ALB and cancer: In all, 356,554 participants were kept in the main analysis after excluding participants under the age of 18, those with prevalent cancer, those with less than one year of follow-up, and those with missing data in CRP, ALB, GLO, PLA, and WBC (Supplementary Figure S1).